Author Identifier (ORCID)

Daniel McAullay: https://orcid.org/0000-0002-0651-899X

Abstract

The prevalence of autoimmune diabetes was assessed in 113 indigenous and 1555 non-indigenous participants in the Fremantle Diabetes Study Phase II. Both type 1 diabetes (3.5% vs. 8.2%) and latent autoimmune diabetes of adults diagnosed based on glutamic acid decarboxylase antibody (GADA) positivity (1.0% vs. 5.7%) were lower in Aboriginal participants (P = 0.101 and 0.039 respectively). Six Aboriginals with GADA-negative type 2 diabetes were positive for tyrosine phosphatase-related islet antigen 2 antibodies but did not exhibit relative insulin deficiency.

Document Type

Journal Article

Date of Publication

4-1-2025

Volume

55

Issue

4

PubMed ID

40099758

Publication Title

Internal Medicine Journal

Publisher

Wiley

School

Kurongkurl Katitjin

Funders

Medical Research Future Fund Practitioner Fellowship (1154192)

Creative Commons License

Creative Commons Attribution 4.0 License
This work is licensed under a Creative Commons Attribution 4.0 License.

Comments

Davis, T. M., Bundell, C. S., Chubb, S. A. P., McAullay, D., & Davis, W. A. (2025). Prevalence of autoimmune diabetes among Aboriginal Australians: The Fremantle Diabetes Study Phase II. Internal Medicine Journal, 55(4), 659-663. https://doi.org/10.1111/imj.70029

First Page

659

Last Page

663

Download

Share

 
COinS
 

Link to publisher version (DOI)

10.1111/imj.70029

Link to publisher version (DOI)

10.1111/imj.70029